{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:49:25Z","timestamp":1786121365458,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003827","name":"National Research Development and Innovation Office","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003827","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.neuropharm.2026.111117","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T23:36:03Z","timestamp":1785368163000},"page":"111117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Intracerebroventricular and intranasal application of alarin reduces body weight in male rats"],"prefix":"10.1016","volume":"299","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0861-5762","authenticated-orcid":false,"given":"Fanni","family":"Polai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5322-4425","authenticated-orcid":false,"given":"Alexandra","family":"Miko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Furedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2830-2732","authenticated-orcid":false,"given":"Balazs","family":"Gaszner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Kofler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4377-9758","authenticated-orcid":false,"given":"Marta","family":"Balasko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3673-8491","authenticated-orcid":false,"given":"Erika","family":"Petervari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2026.111117_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1028982","article-title":"The evolving roles of alarin in physiological and disease conditions, and its future potential clinical implications","volume":"13","author":"Abebe","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.neuropharm.2026.111117_bib2","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.neuron.2015.02.018","article-title":"Pleasure systems in the brain","volume":"86","author":"Berridge","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2026.111117_bib3","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1476-5381.2010.00893.x","article-title":"Alarin stimulates food intake and gonadotrophin release in male rats","volume":"161","author":"Boughton","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111117_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004871","article-title":"Glucagon-like peptide-1 receptor agonists for obesity: growing popularity met with growing questions over safety","volume":"23","author":"Chao","year":"2026","journal-title":"PLoS Med."},{"key":"10.1016\/j.neuropharm.2026.111117_bib5","doi-asserted-by":"crossref","first-page":"R298","DOI":"10.1152\/ajpregu.00674.2005","article-title":"Daily, intermittent intravenous infusion of peptide YY(3\u201336) reduces daily food intake and adiposity in rats","volume":"290","author":"Chelikani","year":"2006","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.neuropharm.2026.111117_bib6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s12031-011-9546-y","article-title":"Distribution of alarin immunoreactivity in the mouse brain","volume":"46","author":"Eberhard","year":"2012","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111117_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-73825-7","article-title":"Activity of the hypothalamic neuropeptide Y increases in adult and decreases in old rats","volume":"14","author":"Eitmann","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2026.111117_bib8","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1159\/000495823","article-title":"High circulating alarin levels are associated with presence of metabolic syndrome","volume":"51","author":"Fang","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.neuropharm.2026.111117_bib9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.npep.2011.12.003","article-title":"Effects of alarin on food intake, body weight and luteinizing hormone secretion in male mice","volume":"46","author":"Fraley","year":"2012","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neuropharm.2026.111117_bib10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.npep.2012.08.007","article-title":"Alarin 6-25Cys antagonizes alarin-specific effects on food intake and luteinizing hormone secretion","volume":"47","author":"Fraley","year":"2013","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neuropharm.2026.111117_bib11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.neuropharm.2017.03.002","article-title":"Melanocortin 4 receptor ligands modulate energy homeostasis through urocortin 1 neurons of the centrally projecting Edinger-Westphal nucleus","volume":"118","author":"F\u00fcredi","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111117_bib13","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12886-022-02403-0","article-title":"Plasma and aqueous levels of alarin and adipsin in patients with and without diabetic retinopathy","volume":"22","author":"G\u00fcl","year":"2022","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.neuropharm.2026.111117_bib12","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/jog.15176","article-title":"Alarin: a new predictive marker in infertile women with polycystic ovary syndrome: a case-control study","volume":"48","author":"Gorkem","year":"2022","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.neuropharm.2026.111117_bib14","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s12031-013-9952-4","article-title":"Galanin-like peptide (GALP) facilitates thermogenesis via synthesis of prostaglandin E2 by astrocytes in the periventricular zone of the third ventricle","volume":"50","author":"Kageyama","year":"2013","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111117_bib15","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.metabol.2018.10.011","article-title":"Obesity and cardiovascular disease: revisiting an old relationship","volume":"92","author":"Koliaki","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.neuropharm.2026.111117_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.862098","article-title":"Age-dependent FOSB\/\u0394FOSB response to acute and chronic stress in the extended amygdala, hypothalamic paraventricular, habenular, centrally-projecting Edinger-Westphal, and dorsal raphe nuclei in male rats","volume":"14","author":"Kov\u00e1cs","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111117_bib17","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1007\/s13311-021-01155-x","article-title":"Intranasal delivery of a methyllanthionine-stabilized galanin receptor-2-selective agonist reduces acute food intake","volume":"18","author":"Kuipers","year":"2021","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuropharm.2026.111117_bib18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pharmthera.2007.05.009","article-title":"The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health and disease","volume":"115","author":"Lang","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2026.111117_bib19","first-page":"983","article-title":"Level of circulating alarin in obese children and its association with insulin resistance","volume":"21","author":"Li","year":"2019","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"10.1016\/j.neuropharm.2026.111117_bib20","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.diabres.2018.05.034","article-title":"The effect of glucagon-like peptide 1 and glucagon-like peptide 1 receptor agonists on energy expenditure: a systematic review and meta-analysis","volume":"142","author":"Maciel","year":"2018","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.neuropharm.2026.111117_bib21","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.3390\/ijms24043390","article-title":"Biomaterials-enhanced intranasal delivery of drugs as a direct route for brain targeting","volume":"24","author":"Marcello","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111117_bib22","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/j.1476-5381.2010.00873.x","article-title":"Guidelines for reporting experiments involving animals: the ARRIVE guidelines","volume":"160","author":"McGrath","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111117_bib23","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.fertnstert.2017.02.104","article-title":"Obesity pandemic: causes, consequences, and solutions-but do we have the will?","volume":"107","author":"Meldrum","year":"2017","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.neuropharm.2026.111117_bib24","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0196-9781(92)90116-K","article-title":"Metabolic effects of galanin injections into the paraventricular nucleus of the hypothalamus","volume":"13","author":"Men\u00e9ndez","year":"1992","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2026.111117_bib25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4161\/temp.29790","article-title":"Thermoregulatory effect of alarin, a new member of the galanin peptide family","volume":"1","author":"Mik\u00f3","year":"2014","journal-title":"Temperature (Austin)"},{"key":"10.1016\/j.neuropharm.2026.111117_bib26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.npep.2016.09.001","article-title":"Acute central effects of alarin on the regulation on energy homeostasis","volume":"64","author":"Mik\u00f3","year":"2017","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neuropharm.2026.111117_bib27","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.cmet.2014.02.007","article-title":"Central neural regulation of brown adipose tissue thermogenesis and energy expenditure","volume":"19","author":"Morrison","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.neuropharm.2026.111117_bib28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/35053570","article-title":"Molecular basis of long-term plasticity underlying addiction","volume":"2","author":"Nestler","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111117_bib29","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1124\/jpet.107.132381","article-title":"Delivery of galanin-like peptide to the brain: targeting with intranasal delivery and cyclodextrins","volume":"325","author":"Nonaka","year":"2008","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2026.111117_bib30","article-title":"Why are we still in need for novel anti-obesity medications?","volume":"47","author":"Novikoff","year":"2024","journal-title":"Lancet Reg. Health Eur."},{"key":"10.1016\/j.neuropharm.2026.111117_bib31","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2007"},{"key":"10.1016\/j.neuropharm.2026.111117_bib32","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S0140-6736(22)02403-5","article-title":"Contemporary medical, device, and surgical therapies for obesity in adults","volume":"401","author":"Perdomo","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2026.111117_bib33","doi-asserted-by":"crossref","first-page":"10594","DOI":"10.1523\/JNEUROSCI.2542-04.2004","article-title":"Induction of deltaFosB in reward-related brain structures after chronic stress","volume":"24","author":"Perrotti","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111117_bib37","article-title":"Effects of central alarin administration on energy balance in male Wistar rats","author":"Polai","year":"2026","journal-title":"Mendeley Data, v1"},{"key":"10.1016\/j.neuropharm.2026.111117_bib34","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.npep.2010.03.002","article-title":"Age-dependence of alpha-MSH-induced anorexia","volume":"44","author":"P\u00e9terv\u00e1ri","year":"2010","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neuropharm.2026.111117_bib36","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.peptides.2014.03.011","article-title":"Age versus nutritional state in the development of central leptin resistance","volume":"56","author":"P\u00e9terv\u00e1ri","year":"2014","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2026.111117_bib35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.regpep.2010.10.002","article-title":"Central alpha-MSH infusion in rats: disparate anorexic vs. metabolic changes with aging","volume":"166","author":"P\u00e9terv\u00e1ri","year":"2011","journal-title":"Regul. Pept."},{"key":"10.1016\/j.neuropharm.2026.111117_bib38","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4161\/23328940.2014.989794","article-title":"A paradoxical role for alarin in the nervous control of energy homeostasis and thermoregulation: orexigenic but hypermetabolic","volume":"2","author":"Roth","year":"2014","journal-title":"Temperature (Austin)"},{"key":"10.1016\/j.neuropharm.2026.111117_bib39","doi-asserted-by":"crossref","first-page":"10217","DOI":"10.1073\/pnas.0608585104","article-title":"Alarin is a vasoactive peptide","volume":"104","author":"Santic","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2026.111117_bib40","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/nn.3159","article-title":"Neural circuitry engaged by prostaglandins during the sickness syndrome","volume":"15","author":"Saper","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111117_bib41","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.neuropharm.2015.09.021","article-title":"Somatostatin receptor subtype 4 activation is involved in anxiety and depression-like behavior in mouse models","volume":"101","author":"Scheich","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111117_bib42","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1042\/CS20070182","article-title":"Increasing the fat-to-carbohydrate ratio in a high-fat diet prevents the development of obesity but not a prediabetic state in rats","volume":"113","author":"Sinitskaya","year":"2007","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.neuropharm.2026.111117_bib43","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/dom.16364","article-title":"Real-world evidence on the utilization, clinical and comparative effectiveness, and adverse effects of newer GLP-1RA-based weight-loss therapies","volume":"27","author":"Thomsen","year":"2025","journal-title":"Diabetes Obes. Metabol."},{"key":"10.1016\/j.neuropharm.2026.111117_bib44","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.npep.2010.04.001","article-title":"Alarin stimulates food intake in male rats and LH secretion in castrated male rats","volume":"44","author":"Van der Kolk","year":"2010","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neuropharm.2026.111117_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017247","article-title":"Brown adipose tissue in morbidly obese subjects","volume":"6","author":"Vijgen","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2026.111117_bib46","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.peptides.2014.04.009","article-title":"Alarin-induced antidepressant-like effects and their relationship with hypothalamus-pituitary-adrenal axis activity and brain derived neurotrophic factor levels in mice","volume":"56","author":"Wang","year":"2014","journal-title":"Peptides"},{"key":"10.1016\/j.neuropharm.2026.111117_bib47","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bbr.2014.11.039","article-title":"Antidepressant-like effects of alarin produced by activation of TrkB receptor signaling pathways in chronic stress mice","volume":"280","author":"Wang","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2026.111117_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2020.102021","article-title":"Superoxide anions modulate the effects of alarin in the paraventricular nucleus on sympathetic activity and blood pressure in spontaneously hypertensive rats","volume":"80","author":"Wang","year":"2020","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neuropharm.2026.111117_bib50","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2147\/DMSO.S290072","article-title":"Plasma alarin level and its influencing factors in obese newly diagnosed type 2 diabetes patients","volume":"14","author":"Zhou","year":"2021","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.neuropharm.2026.111117_bib51","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.bbr.2016.06.057","article-title":"The antidepressant-like effect of alarin is related to TrkB-mTOR signaling and synaptic plasticity","volume":"313","author":"Zhuang","year":"2016","journal-title":"Behav. Brain Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826002923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826002923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T04:26:17Z","timestamp":1786076777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826002923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":50,"alternative-id":["S0028390826002923"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111117","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intracerebroventricular and intranasal application of alarin reduces body weight in male rats","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111117","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"111117"}}